All Research Articles

1,801-1,820 of 2,301 ARTICLES
https://doi.org/10.12688/f1000research.10422.2
Opinion Article metrics
Revised
Building the infrastructure to make science metrics more scientific
[version 2; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers David J. Currie; Maria Nedeva; Ivan Oransky and Alison Abritis
LATEST VERSION PUBLISHED 07 Apr 2017
https://doi.org/10.12688/f1000research.10768.1
Review metrics
Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy
[version 1; peer review: 3 approved]
Peer Reviewers Chris Halsey; Anne Uyttebroeck; Jan Stary
  • Funders
  • Danish Cancer Society
  • Danish Childhood Cancer Foundation
PUBLISHED 07 Apr 2017
https://doi.org/10.12688/f1000research.10485.1
Review metrics
Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease
[version 1; peer review: 3 approved]
Peer Reviewers Alanna Watt and Visou Ady; Maria Concetta Miniaci; Ferdinando Nicoletti
  • Funders
  • AMED, Japan
  • Japan Society for the Promotion of Science
PUBLISHED 04 Apr 2017
https://doi.org/10.12688/f1000research.10233.1
Review metrics
New drugs in psychiatry: focus on new pharmacological targets
[version 1; peer review: 3 approved]
Peer Reviewers S. J. Enna; Philippe De Deurwaerdère; Andrzej Pilc and Michal Korostynski
PUBLISHED 30 Mar 2017
https://doi.org/10.12688/f1000research.10570.2
Research Note metrics
Revised
Engaging high school students in neuroscience research -through an e-internship program
[version 2; peer review: 3 approved]
Peer Reviewers Christine F. Hohmann; Byron C. Jones; Jennifer A. Ufnar
LATEST VERSION PUBLISHED 29 Mar 2017
https://doi.org/10.12688/f1000research.10475.1
Review metrics
Bringing a genomic perspective to the safety of drug treatment in oncology
[version 1; peer review: 3 approved]
Peer Reviewers Cristina Rodríguez-Antona; Giuliano Ciarimboli; Emile Voest
PUBLISHED 29 Mar 2017
https://doi.org/10.12688/f1000research.10476.1
Review metrics
What causes amyotrophic lateral sclerosis?
[version 1; peer review: 3 approved]
Peer Reviewers Robert P. Bowser; Richard W Orrell; Mamede de Carvalho
PUBLISHED 28 Mar 2017
https://doi.org/10.12688/f1000research.10594.1
Review metrics
Studying human immunodeficiencies in humans: advances in fundamental concepts and therapeutic interventions
[version 1; peer review: 3 approved]
Peer Reviewers Ramsay Fuleihan; Jordan Orange; Andrew Gennery
  • Funder
  • National Institute of Allergy and Infectious Diseases
PUBLISHED 24 Mar 2017
https://doi.org/10.12688/f1000research.10739.1
Review metrics
Recent advances in understanding spondyloarthritis
[version 1; peer review: 2 approved]
Peer Reviewers Denis Poddubnyy; Robert A. Colbert
PUBLISHED 22 Mar 2017
https://doi.org/10.12688/f1000research.9609.1
Review metrics
Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective
[version 1; peer review: 2 approved]
Peer Reviewers William McBride; William Griffin
PUBLISHED 21 Mar 2017
https://doi.org/10.12688/f1000research.9692.1
Review metrics
Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy
[version 1; peer review: 3 approved]
Peer Reviewers AK Johnson; Anton van den Meiracker; Bertram Pitt
PUBLISHED 21 Mar 2017
https://doi.org/10.12688/f1000research.10408.1
Review metrics
Recent Advances in Pediatric Ventilatory Assistance
[version 1; peer review: 2 approved]
Peer Reviewers Thomas Keens; Robert DiBlasi
PUBLISHED 17 Mar 2017
https://doi.org/10.12688/f1000research.10860.1
Opinion Article metrics
Reframing the science and policy of nicotine, illegal drugs and alcohol – conclusions of the ALICE RAP Project
[version 1; peer review: 2 approved]
Peer Reviewers Richard L. Bell; Freya Vander Laenen and Nick Verhaeghe
  • Funder
  • Seventh Framework Programme
PUBLISHED 17 Mar 2017
https://doi.org/10.12688/f1000research.10587.1
Review metrics
Recent advances in managing and understanding uveitis
[version 1; peer review: 3 approved]
Peer Reviewers Carlos Pavesio; C Stephen Foster; Peter McCluskey
PUBLISHED 16 Mar 2017
https://doi.org/10.12688/f1000research.10538.1
Review metrics
How are base excision DNA repair pathways deployed in vivo?
[version 1; peer review: 4 approved]
Peer Reviewers Michael J. Smerdon; Arne Klungland; Samuel Wilson; Vilhelm Bohr
  • Funder
  • U.S. National Cancer Institute
PUBLISHED 16 Mar 2017
https://doi.org/10.12688/f1000research.9701.1
Review metrics
Recent advances in understanding and preventing human papillomavirus-related disease
[version 1; peer review: 3 approved]
Peer Reviewers Marc Arbyn; Yin Ling Woo; Sarah Fidler
PUBLISHED 14 Mar 2017
https://doi.org/10.12688/f1000research.10100.1
Review metrics
Recent advances in treating Parkinson’s disease
[version 1; peer review: 2 approved]
Peer Reviewers Mark Hallett; Peter LeWitt
PUBLISHED 13 Mar 2017
https://doi.org/10.12688/f1000research.10364.1
Review metrics
C3 glomerulopathy
[version 1; peer review: 4 approved]
Peer Reviewers Arvind Bagga; Francesco Emma and Marina Vivarelli; Minghui Zhao; John D. Lambris
  • Funder
  • Wellcome Trust
PUBLISHED 10 Mar 2017
https://doi.org/10.12688/f1000research.9402.1
Review metrics
Recent advances in understanding and managing gout
[version 1; peer review: 2 approved]
Peer Reviewers N. Lawrence Edwards; Richard Day
PUBLISHED 10 Mar 2017
https://doi.org/10.12688/f1000research.10842.1
Research Article metrics PEER REVIEW DISCONTINUED
Engaging bioscientists in science communication: Evidence from an international survey
[version 1; peer review: 1 not approved]
Peer Reviewers Vickie Curtis
  • Funder
  • Cariplo Foundation
PUBLISHED 02 Mar 2017
1,801-1,820 of 2,301 ARTICLES
Articles
We publish a wide range of article types in science, engineering, medicine, social sciences and humanities, with no editorial biases.
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.